Syncona Limited (SYNC) Ordinary NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership) in which the Company is the sole limited partner. The general partner of the Partnership is Syncona GP Limited (the General Partner), a wholly owned subsidiary of the Company. Syncona Investment Management Limited is its alternative investment manager.
Important dates
General stock information
- EPIC:
- SYNC
- ISIN:
- GG00B8P59C08
- Market cap:
- £626.31 million
- Shares in issue:
- 627.56 million
- Sector:
- Equity Investment Instruments
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- FTSE 250,FTSE 350,FTSE All Share
Contact details
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.